ULTRALIFE CORP
corporate_fare Company Profile
ULTRALIFE CORP (NASDAQ:ULBI) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 12 items for ULBI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-07, rated 8/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for ULBI spans 10-Q, DEF 14A, 4, 8-K.
Recent high-impact activity:
- Ultralife Q2 2026: Record Backlog and Margin Expansion Overshadowed by Unremediated Material Weakness
- Annual Meeting Proxy Details: Missed Executive Bonuses & 40.3% Insider Ownership Confirmed
- ULTRALIFE Director & 10% Owner Buys $715K in Open Market
- Ultralife Reports Q1 Net Loss and Revenue Decline Amidst Ongoing Material Weakness in Internal Controls
- Ultralife Reports Q1 Net Loss and Revenue Decline Amid Operational Challenges; Backlog Hits Record High
Financial Snapshot
Short Interest & Short Volume
2.60 days to coverFINRA reported short interest of 104,662 shares in ULBI as of the September 15, 2026 settlement, a 5.5% decrease from the prior period — about 2.6 days to cover at its recent average daily volume. On October 2, 2026, 41.7% of ULBI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.